Appendix 3B

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B  Page 1 
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
 
Appendix 3B 
 
New issue announcement, 
application for quotation of additional securities 
and agreement 
 
Information or documents not available now must be given to ASX as soon as available.  Information and 
documents given to ASX become ASX’s property and may be made public. 
Introduced 01/07/96  Origin: Appendix 5  Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 
04/03/13 
 
 
Name of entity 
MICHAEL HILL INTERNATIONAL LIMITED 
 
ABN 
25 610 937 598 
 
We (the entity) give ASX the following information. 
 
 
Part 1 ‐ All issues 
You must complete the relevant sections (attach sheets if there is not enough space). 
 
1 
+
Class of 
+
securities issued or to 
be issued 
 
Unlisted share rights (Share Rights) 
 
  
2 Number of 
+
securities issued or 
to be issued (if known) or 
maximum number which may 
be issued 
 
382,551 
 
  

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 2 04/03/2013 
3 Principal terms of the 
+
securities (e.g. if options, 
exercise price and expiry date; if 
partly paid 
+
securities, the 
amount outstanding and due 
dates for payment; if 
+
convertible securities, the 
conversion price and dates for 
conversion) 
The Share Rights are issued pursuant to and on the terms of 
the Company’s Incentive Plan approved by shareholders at 
the Company’s AGM on 31 October 2016 (Plan) and the 
invitation provided to each Participant (Invitation).  
 
Upon exercise, the Company will (subject to the Participant’s 
Invitation) issue, allocate or 
cause to be transferred to that 
Participant the number of MHJ fully paid ordinary shares 
(Shares) to which the Participant is entitled.   
 
Shares issued upon exercise of the Share Rights (Resulting 
Shares) will rank equally with all other shares on issue in 
that class. 
 
 
186,613 of the Share Rights (Employee Share Rights) are issued 
on the basis that they are divided into 3 tranches and vest as 
follows: 
1. Tranche 1 ‐ 25% of Share Rights  
25% of the Share Rights granted to participants will vest if 
the participant has been continuously engaged under
 an 
Engagement Arrangement (and have not resigned or been 
terminated) from the grant date to the date which is 3 
years from 1 July 2016 (Reference Financial Year).  
2. Tranche 2 ‐ 25% of Share Rights  
25% of the Share Rights granted to participants will vest if 
the participant has 
been continuously engaged under an 
Engagement Arrangement (and have not resigned or been 
terminated) from the grant date to the date which is 4 
years from 1 July in the Reference Financial Year.  
3. Tranche 3 ‐ 50% of Share Rights  
50% of the Share Rights granted to participants will vest if
 
the participant has been continuously engaged under an 
Engagement Arrangement (and have not resigned or been 
terminated) from the grant date to the date which is 5 
years from 1 July in the Reference Financial Year. 
195,938 of the Share Rights (CFO Share Rights) are issued on the 
basis 
that 100% will vest if the participant has been continuously 
engaged under an Engagement Arrangement (and has not 
resigned or been terminated) from the grant date to the date 
which is 3 years from the Reference Financial Year. 
 
 
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B  Page 3 
  
 
4 Do the 
+
securities rank equally 
in all respects from the 
+
issue 
date with an existing 
+
class of 
quoted 
+
securities? 
 
If the additional 
+
securities do 
not rank equally, please state: 
 the date from which they do 
 the extent to which they 
participate for the next 
dividend, (in the case of a 
trust, distribution) or 
interest payment 
 the extent to which they do 
not rank equally, other than 
in relation to the
 next 
dividend, distribution or 
interest payment 
No.  The Company’s only class of quoted 
securities are ordinary shares.  The 
securities issued under this 
Appendix 3B are share rights (not 
shares) and as such do not rank 
equally with the Company’s 
ordinary shares in any respect.  
 
Upon exercise of vested Share Rights, the 
resulting shares will rank equally with
 
ordinary shares on issue. 
 
Prior to a Share Right being exercised a 
participant is not entitled to receive any 
dividends declared by the Company. 
  
 
5 Issue price or consideration 
 
Nil 
 
  
 
6 Purpose of the issue 
(If issued as consideration for 
the acquisition of assets, clearly 
identify those assets) 
 
 
 
 
 
 
Pursuant to Company’s Incentive Plan as 
approved at the Annual General Meeting of 
Shareholders on 31 October 2016. 
 
 
 
  
6a Is the entity an 
+
eligible entity 
that has obtained security 
holder approval under rule 7.1A? 
 
If Yes, complete sections 6b – 6h 
in relation to the 
+
securities the 
subject of this Appendix 3B, and 
comply with section 6i 
No 
 
  
6b The date the security holder 
resolution under rule 7.1A was 
passed 
N/A 
 
  
6c Number of 
+
securities issued 
without security holder 
approval under rule 7.1 
Nil 
 
  

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 4 04/03/2013 
6d Number of 
+
securities issued 
with security holder approval 
under rule 7.1A 
Nil 
 
  
6e Number of 
+
securities issued 
with security holder approval 
under rule 7.3, or another 
specific security holder approval 
(specify date of meeting) 
 
Nil 
 
  
6f Number of 
+
securities issued 
under an exception in rule 7.2 
382,551 
 
  
6g If 
+
securities issued under rule 
7.1A, was issue price at least 75% 
of 15 day VWAP as calculated 
under rule 7.1A.3?  Include the 
+
issue date and both values.  
Include the source of the VWAP 
calculation. 
N/A 
 
  
6h If 
+
securities were issued under 
rule 7.1A for non‐cash 
consideration, state date on 
which valuation of 
consideration was released to 
ASX Market Announcements 
N/A 
 
  
6i Calculate the entity’s remaining 
issue capacity under rule 7.1 and 
rule 7.1A – complete Annexure 1 
and release to ASX Market 
Announcements 
58,115,776
 
 
  
7 
+
Issue dates 
Note: The issue date may be prescribed by 
ASX (refer to the definition of issue date in 
rule 19.12).  For example, the issue date for a 
pro rata entitlement issue must comply with 
the applicable timetable in Appendix 7A. 
Cross reference: item 33 of Appendix 3B. 
20 March 2017 
  
 
  
Number 
+
Class 
8 Number and 
+
class of all 
+
securities quoted on ASX 
(including the 
+
securities in 
section 2 if applicable) 
 
 
 
387,438,513 ORD 
 
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B  Page 5 
 
  
Number 
+
Class 
9 Number and 
+
class of all 
+
securities not quoted on ASX 
(including the 
+
securities in 
section 2 if applicable) 
 
 
 
5,250,000 
 
 
 
 
382,551 
Various classes of 
unlisted options 
(details provided in 
Annexure A). 
 
Various unlisted 
Share Rights (details 
provided in 
Annexure A). 
  
 
10 Dividend policy (in the case of a 
trust, distribution policy) on the 
increased capital (interests) 
Prior to a Share Right being exercised a 
participant is not entitled to receive any 
dividends declared by the Company. 
 
Part 2 ‐ Pro rata issue 
 
11 Is security holder approval 
required? 
 
N/A 
  
 
12 Is the issue renounceable or non‐
renounceable? 
N/A 
  
 
13 Ratio in which the 
+
securities 
will be offered 
N/A 
  
 
14 
+
Class of 
+
securities to which the 
offer relates 
N/A 
  
 
15 
+
Record date to determine 
entitlements 
N/A 
 
  
 
16 Will holdings on different 
registers (or subregisters) be 
aggregated for calculating 
entitlements? 
N/A 
  
 
17 Policy for deciding entitlements 
in relation to fractions 
 
N/A 
  
 
18 Names of countries in which the 
entity has security holders who 
will not be sent new offer 
documents 
Note: Security holders must be told how their 
entitlements are to be dealt with. 
Cross reference: rule 7.7. 
N/A 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 6 04/03/2013 
19 Closing date for receipt of 
acceptances or renunciations 
N/A 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B  Page 7 
   
20 Names of any underwriters 
 
 
N/A 
  
 
21 Amount of any underwriting fee 
or commission 
N/A 
  
 
22 Names of any brokers to the 
issue 
 
 
N/A 
  
 
23 Fee or commission payable to 
the broker to the issue 
N/A 
  
 
24 Amount of any handling fee 
payable to brokers who lodge 
acceptances or renunciations on 
behalf of security holders 
N/A 
  
 
25 If the issue is contingent on 
security holders’ approval, the 
date of the meeting 
N/A 
  
 
26 Date entitlement and acceptance 
form and offer documents will be 
sent to persons entitled 
N/A 
  
 
27 If the entity has issued options, 
and the terms entitle option 
holders to participate on 
exercise, the date on which 
notices will be sent to option 
holders 
N/A 
  
 
28 Date rights trading will begin (if 
applicable) 
N/A 
  
 
29 Date rights trading will end (if 
applicable) 
 
 
N/A 
  
 
30 How do security holders sell 
their entitlements in full through 
a broker? 
N/A 
  
 
31 How do security holders sell part 
of their entitlements through a 
broker and accept for the 
balance? 
N/A 
  
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 8 04/03/2013 
 
32 How do security holders dispose 
of their entitlements (except by 
sale through a broker)? 
N/A 
  
 
33 
+
Issue date 
 
 
N/A 
 
 
Part 3 ‐ Quotation of securities 
You need only complete this section if you are applying for quotation of securities 
 
34 Type of 
+
securities 
(tick one) 
 
(a) 
 
+
Securities described in Part 1 
   
 
(b) 
 
All other 
+
securities 
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, 
employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible 
securities 

Entities that have ticked box 34(a) 
 
Additional securities forming a new class of securities 
 
 
Tick to indicate you are providing the information or 
documents 
  
 
35 

If the 
+
securities are 
+
equity securities, the names of the 20 largest holders of the 
additional 
+
securities, and the number and percentage of additional 
+
securities 
held by those holders 
  
 
36 

If the 
+
securities are 
+
equity securities, a distribution schedule of the additional 
+
securities setting out the number of holders in the categories 
1 ‐ 1,000 
1,001 ‐ 5,000 
5,001 ‐ 10,000 
10,001 ‐ 100,000 
100,001 and over 
  
 
37 

A copy of any trust deed for the additional 
+
securities 
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B  Page 9 

Entities that have ticked box 34(b) 

38 Number of 
+
securities for which 
+
quotation is sought 
 
N/A 
 
 
 
39 
+
Class of 
+
securities for which 
quotation is sought 
 
N/A 
  
 
40 Do the 
+
securities rank equally in 
all respects from the 
+
issue date 
with an existing 
+
class of quoted 
+
securities? 
 
If the additional 
+
securities do 
not rank equally, please state: 
 the date from which they do 
 the extent to which they 
participate for the next 
dividend, (in the case of a 
trust, distribution) or interest 
payment 
 the extent to which they do 
not rank equally, other than in 
relation to the
 next dividend, 
distribution or interest 
payment 
N/A 
  
 
41 Reason for request for quotation 
now  
Example: In the case of restricted securities, end 
of restriction period 
 
(if issued upon conversion of 
another 
+
security, clearly identify 
that other 
+
security) 
N/A 
  
 
  
Number 
+
Class 
42 Number and 
+
class of all 
+
securities quoted on ASX 
(including the 
+
securities in 
clause 38)  
 
 
 
N/A N/A 
 
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 10 04/03/2013 

 
Quotation agreement 
 
1 
+
Quotation of our additional 
+
securities is in ASX’s absolute discretion.  ASX 
may quote the 
+
securities on any conditions it decides.   
 
2 We warrant the following to ASX. 
 
 The issue of the 
+
securities to be quoted complies with the law and is 
not for an illegal purpose. 
 
 There is no reason why those 
+
securities should not be granted 
+
quotation. 
 
 An offer of the 
+
securities for sale within 12 months after their issue 
will not require disclosure under section 707(3) or section 1012C(6) of 
the Corporations Act. 
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be 
able to give this warranty 

 Section 724 or section 1016E of the Corporations Act does not apply to 
any applications received by us in relation to any 
+
securities to be 
quoted and that no‐one has any right to return any 
+
securities to be 
quoted under sections 737, 738 or 1016F of the Corporations Act at the 
time that we request that the 
+
securities be quoted. 
 
 If we are a trust, we warrant that no person has the right to return the 
+
securities to be quoted under section 1019B of the Corporations Act at 
the time that we request that the 
+
securities be quoted. 

3 We will indemnify ASX to the fullest extent permitted by law in respect of any 
claim, action or expense arising from or connected with any breach of the 
warranties in this agreement. 
 
4 We give ASX the information and documents required by this form.  If any 
information or document is not available now, we will give it to ASX before 
+
quotation of the 
+
securities begins.  We acknowledge that ASX is relying on 
the information and documents.  We warrant that they are (will be) true and 
complete. 
 
 
Sign here:  ............................................................ Date: ......................... 
  (Director/Company secretary) 
 
Print name:  Mary‐Anne Greaves 
 
== == == == == 
 
21 March 2017

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B Page 11 
Appendix 3B – Annexure 1 
 
Calculation of placement capacity under rule 7.1 and rule 
7.1A for eligible entities 
Introduced 01/08/12  Amended 04/03/13 
 
Part 1 
 
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
Insert number of fully paid
+
ordinary
securities on issue 12 months before the
+
issue date or date of agreement to issue
383,138,513
Add the following:
• Number of fully paid
+
ordinary securities
issued in that 12 month period under an
exception in rule 7.2
• Number of fully paid
+
ordinary securities
issued in that 12 month period with
shareholder approval
• Number of partly paid
+
ordinary
securities that became fully paid in that
12 month period
Note:
• Include only ordinary securities here –
other classes of equity securities cannot
be added
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
200,000 (issued 24/11/16)
3,600,000 (issued 8/11/16)
500,000 (issued 22/9/16)

4,300,000 (Total)
Subtract the number of fully paid
+
ordinary
securities cancelled during that 12 month
period
0
“A”
387,438,513

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 12 04/03/2013 
 
Step 2: Calculate 15% of “A”
“B”
0.15
[Note: this value cannot be changed]
Multiply “A” by 0.15
58,115,776
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period not counting those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the
securities the subject of the Appendix
3B to which this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
0
“C” 0
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
58,115,776
Subtract “C”
Note: number must be same as shown in
Step 3
0
Total [“A” x 0.15] – “C”
58,115,776
[Note: this is the remaining placement
capacity under rule 7.1]
 

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
04/03/2013 Appendix 3B Page 13 
Part 2 
 
Rule 7.1A – Additional placement capacity for eligible entities
Step 1: Calculate “A”, the base figure from which the placement
capacity is calculated
“A”
Note: number must be same as shown in
Step 1 of Part 1
N/A
Step 2: Calculate 10% of “A”
“D”
0.10
Note: this value cannot be changed
Multiply “A” by 0.10
N/A
Step 3: Calculate “E”, the amount of placement capacity under rule
7.1A that has already been used
Insert number of
+
equity securities issued
or agreed to be issued in that 12 month
period under rule 7.1A
Notes:
• This applies to equity securities – not
just ordinary securities
• Include here – if applicable – the
securities the subject of the Appendix
3B to which this form is annexed
• Do not include equity securities issued
under rule 7.1 (they must be dealt with
in Part 1), or for which specific security
holder approval has been obtained
• It may be useful to set out issues of
securities on different dates as separate
line items
N/A
“E”
N/A

Appendix 3B 
New issue announcement 
 
 
 
+ See chapter 19 for defined terms. 
 
Appendix 3B Page 14 04/03/2013 
 
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
N/A
Subtract “E”
Note: number must be same as shown in
Step 3
N/A
Total [“A” x 0.10] – “E”
N/A
Note: this is the remaining placement
capacity under rule 7.1A
 
 
 

Michael Hill International L
imited ABN 25
610 937 598
Appendix 3B Appendix A – Details of Unlisted Options
Name
Issue Date (date
of
agreement)
V
esting Date
Number of Employee Options as at the date of this
A
ppendix
3B
Exercise Price ($NZ)
Exercise Period
V
ested
Unvested
Total
Phil Taylor
7/11/2007
7/11/2007
750,000


$1.25
17/8/12 - 30/9/17
18/12/2009 18/12/2009
150,000


$0.94
15/8/14 - 30/9/19
18/12/2009 17/09/2010
150,000


$0.88
14/8/15 - 30/9/20
18/12/2009 16/09/2011
150,000


$1.16
See Note 7
18/12/2009 19/09/2012
150,000


$1.41
See Note 8
18/12/2009 18/09/2013
150,000


$1.82
See Note 9
2/12/2013
2/12/2013

750,000


$1.82
See Note 10




2,250,000


Stewart Silk
2/12/2013
2/12/2013

500,000

$1.82
See Note 11
2/12/2013
18/09/2014
100,000


$1.63
See Note 12
2/12/2013
22/01/2016
100,000


$1.14
See Note 13
2/12/2013
N/A

300,000

See Note 1
See Note 2




1,000,000


Galina Hirtzel
2/12/2013
2/12/2013

500,000

$1.82
See Note 11
2/12/2013
18/09/2014
100,000


$1.63
See Note 12
2/12/2013
22/01/2016
100,000


$1.14
See Note 13
2/12/2013
N/A

300,000

See Note 1
See Note 2




1,000,000


Brett Halliday




500,000

22/09/2009 22/09/2009
100,000

$0.94
15/8/14 - 30/9/19
Kevin Stock
17/09/2010 17/09/2010
100,000


$0.88
14/8/15 - 30/9/20
16/09/2011 16/09/2011
100,000


$1.16
See Note 14

16/09/2011 19/09/2012
100,000


$1.41
See Note 15
16/09/2011 18/09/2013
100,000


$1.82
See Note 16




500,000














12,050,000

600,000

12,650,000



Total






Note 1:
The options will vest in 3 equal tranches (
Tranches
) in September 2016, September 2017 and September 2018 (
Tranche Year
). Upon vesting, the exercise p
rice per ordinary share will be

30% above the volume weighted average price of the Company's or
dinary shares in the 20 business days following the ASX announc
ement in August of the relevant year of the Company's results f
or
the financial year immediately
preceding the relevant calendar
year.
Note 2:
For each Tranche, the exercise
period is the period immediatel
y following the announcement of the Company's annual financial
results for the financial year ending on 30 September in the 5t
h
year after the Tranche Year.

Note 3:
Exercise period commences immedi
ately following the announceme
nt of the Company's annual financial results for the year endin
g 30 June 2018 to NZX (or any other registered securities
exchange on which the Company's Ordinary Shares are at the rele
vant time listed) and ending on 30 September 2023.
Note 4:
Exercise period commences immedi
ately following the announceme
nt of the Company's annual financial results for the year endin
g 30 June 2016 through to 30 September 2021.

Note 5:
Exercise period commences immediately following the announcemen
t of the Company's annual financial results for the year ending
30 June 2017 through to 30 September 2022.
Note 6:
Exercise period commences immedi
ately following the announceme
nt of the Company's annual financial results for the year endin
g 30 June 2018 through to 30 September 2023.
Note 7:
Exercise period commences on t
he date immediately following th
e announcement of the Company's annual financial results for th
e year ending 30 June 2014 and ends on 30 September 2019.
Note 7:
Exercise period commences on t
he date immediately following th
e announcement of the Company's annual financial results for th
e year ending 30 June 2014 and ends on 30 September 2019.
Note 8:
Exercise period commences on t
he date immediately following t
he announcement of the Company's annual financial results for t
he year ending 30 June 2015 and ends on 30 September 2020.
Note 9:
Exercise period commences on t
he date immediately following t
he announcement of the Company's annual financial results for t
he year ending 30 June 2016 and ends on 30 September 2021.
Note 10:
Exercise period commences imm
ediately following the announcemen
t of the Company's annual financial results for the year ending
30 June 2018 and ending on 30 September 2023.
Note 11:
Exercise period commences on t
he date immediately following th
e announcement of the Company's annual financial results for th
e year ending 30 June 2018 and ends on 30 September 2023.
Note 12:
Exercise period commences on the date immediately following the
announcement of the Company's annual financial results for the
year ending 30 June 2019 and ends on 30 September 2024.

Note 13:
Exercise period commences on t
he date immediately following th
e announcement of the Company's annual financial results for th
e year ending 30 June 2020 and ends on 30 September 2025.
Note 14:
Exercise period commences on t
he date immediately following t
he announcement of the Company's annual financial results for t
he year ending 30 June 2016 and ends on 30 September 2021.
Note 15:
Exercise period commences on t
he date immediately following t
he announcement of the Company's annual financial results for t
he year ending 30 June 2017 and ends on 30 September 2022.
Note 16:
Exercise period commences on t
he date immediately following t
he announcement of the Company's annual financial results for t
he year ending 30 June 2018 and ends on 30 September 2023.

Appendix A – Details of Unlisted Share Rights
Name
Share Rights
Issue Date (date
of
agreement)
V
esting Date
Number of Share Rights as at the date of this Appendix 3B
Exercise Price
Exercise Period
V
ested
Unvested
Total
Phil Taylor
Employee Share Rights 20.03.2017 1 July 2
019
0
16,913

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
020
0
16,913

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)

Employee Share Rights 20.03.2017 1 July 2
021
0
33,829

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)



67,655

Galina Hirtzel
Employee Share Rights 20.03.2017 1 July 2
019
0
5,456

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
020
0
5,456

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
021
0
10,912

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)


21,824

Stewart Silk
Employee Share Rights 20.03.2017 1 July 2
019
0
4,621

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
020
0
4,621

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
021
0
9,242

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)


18,484

Kevin Stock
Employee Share Rights 20.03.2017 1 July 2
019
0
7,280

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
020
0
7,280

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
021
0
14,560

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)


29,120

Brett Halliday
Employee Share Rights 20.03.2017 1 July 2
019
0
6,369

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)

Name
Share Rights
Issue Date (date
of
agreement)
V
esting Date
Number of Share Rights as at the date of this Appendix 3B
Exercise Price
Exercise Period
V
ested
Unvested
Total
Employee Share Rights 20.03.2017 1 July 2
020
0
6,369

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
021
0
12,741

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)


25,479

Matt Keays
Employee Share Rights 20.03.2017 1 July 2
019
0
6,012

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
020
0
6,012

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
Employee Share Rights 20.03.2017 1 July 2
021
0
12,027

Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)


24,051

TOTAL EMPLOYEE SHARE RIGHTS


186,613


Name
Share Rights
Issue Date (date
of
agreement)
V
esting Date
Number of Share Rights as at the date of this Appendix 3B
Exercise Price
Exercise Period
V
ested
Unvested
Total
Phil Taylor
CFO Share Rights
20.03.2017 1 Ju
ly 2019
0
195,938
195,938
Not applicable
15
th
anniversary of the Grant Date (i.e. 1
July 2016)
TOTAL CFO SHARE RIGHTS


195,938